Carregant...
Nafamostat mesylate attenuates the pathophysiologic sequelae of neurovascular ischemia
Nafamostat mesylate, an apparent soi-disant panacea of sorts, is widely used to anticoagulate patients undergoing hemodialysis or cardiopulmonary bypass, mitigate the inflammatory response in patients diagnosed with acute pancreatitis, and reverse the coagulopathy of patients experiencing the common...
Guardat en:
| Publicat a: | Neural Regen Res |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wolters Kluwer - Medknow
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7749469/ https://ncbi.nlm.nih.gov/pubmed/32594033 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1673-5374.284981 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|